Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Granger

Showing results (171-180 of 910) with videos related to

Pageof 91
Sort By:
Critical Care Medicine|March 10, 2015
Patient load effects on response time to critical arrhythmias in cardiac telemetry: a randomized trialNoa Segall, Gene Hobbs, Christopher B Granger, et al.
The American Journal of Medicine|July 19, 2025
Bridging the gap: From early recognition to timely referral for cardiac implantable electronic devices infectionsM Rizwan Sohail, Sarwat Khalil, Molly L Paras, et al.
Journal of Electrocardiology|May 7, 2010
Do baseline atrial electrocardiographic and infarction patterns predict new-onset atrial fibrillation after ST-elevation myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction TrialSean van Diepen, Hany Siha, Yuling Fu, et al.
American Heart Journal|October 18, 2003
Does 24-hour ST-segment resolution postfibrinolysis add prognostic value to a Q wave? An ASSENT 2 electrocardiographic substudyEvan Lockwood, Yuling Fu, Brian Wong, et al.
The American Journal of Cardiology|July 6, 2011
Diagnosing acute myocardial infarction in patients with left bundle branch blockRenato D Lopes, Hany Siha, Yuling Fu, et al.
American Heart Journal|August 10, 2010
Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) SubstudyJustin A Ezekowitz, Paul W Armstrong, Christopher B Granger, et al.
American Heart Journal|October 12, 2010
Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) TrialMustafa Toma, Yuling Fu, Justin A Ezekowitz, et al.
European Heart Journal|December 8, 2025
Non-ST-segment elevation acute coronary syndrome: understanding the full spectrum to guide managementStefano Savonitto, Joseph S Alpert, Holger Thiele, et al.
The Canadian Journal of Cardiology|January 7, 2023
Targeted Temperature Management After Out-of-Hospital Cardiac Arrest: Integrating Evidence Into Real World PracticeMadeleine Barker, Mypinder Sekhon, Konstantin A Krychtiuk, et al.
Current Cardiology Reports|November 24, 2011
Promise of factor Xa inhibition in atrial fibrillationSana M Al-Khatib, John H Alexander, Renato D Lopes, et al.
Pageof 91

Showing results (171-180 of 910) with videos related to

Sort By:
Pageof 91
Critical Care Medicine|March 10, 2015
Patient load effects on response time to critical arrhythmias in cardiac telemetry: a randomized trialNoa Segall, Gene Hobbs, Christopher B Granger, et al.
The American Journal of Medicine|July 19, 2025
Bridging the gap: From early recognition to timely referral for cardiac implantable electronic devices infectionsM Rizwan Sohail, Sarwat Khalil, Molly L Paras, et al.
Journal of Electrocardiology|May 7, 2010
Do baseline atrial electrocardiographic and infarction patterns predict new-onset atrial fibrillation after ST-elevation myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction TrialSean van Diepen, Hany Siha, Yuling Fu, et al.
American Heart Journal|October 18, 2003
Does 24-hour ST-segment resolution postfibrinolysis add prognostic value to a Q wave? An ASSENT 2 electrocardiographic substudyEvan Lockwood, Yuling Fu, Brian Wong, et al.
The American Journal of Cardiology|July 6, 2011
Diagnosing acute myocardial infarction in patients with left bundle branch blockRenato D Lopes, Hany Siha, Yuling Fu, et al.
American Heart Journal|August 10, 2010
Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) SubstudyJustin A Ezekowitz, Paul W Armstrong, Christopher B Granger, et al.
American Heart Journal|October 12, 2010
Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) TrialMustafa Toma, Yuling Fu, Justin A Ezekowitz, et al.
European Heart Journal|December 8, 2025
Non-ST-segment elevation acute coronary syndrome: understanding the full spectrum to guide managementStefano Savonitto, Joseph S Alpert, Holger Thiele, et al.
The Canadian Journal of Cardiology|January 7, 2023
Targeted Temperature Management After Out-of-Hospital Cardiac Arrest: Integrating Evidence Into Real World PracticeMadeleine Barker, Mypinder Sekhon, Konstantin A Krychtiuk, et al.
Current Cardiology Reports|November 24, 2011
Promise of factor Xa inhibition in atrial fibrillationSana M Al-Khatib, John H Alexander, Renato D Lopes, et al.
Pageof 91